Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating an internal site release without changing the study history details shown.
    Difference
    0.1%
    Check dated 2026-04-25T06:13:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the history; Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-18T03:55:00.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:20.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the record history. Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:15.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the Record History; removed the funding-status notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T14:23:22.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and release version v3.4.1. Removed release version v3.4.0.
    Difference
    0.8%
    Check dated 2026-02-04T10:29:08.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.